Maternal Serum Amyloid A as a Marker of Preterm Birth/PROM: A Systematic Review and Meta-Analysis
Abstract
:1. Introduction
2. Materials and Methods
2.1. Eligibility Criteria
2.2. Information Sources
2.3. Search Strategy
2.4. Study Selection
2.5. Data Collection
2.6. Study Risk of Bias Assessment
2.7. Synthesis Methods
3. Results
3.1. Study Selection
3.2. Study Characteristics
3.3. Risk of Bias in Studies
3.4. Results of Syntheses
3.5. Publication Bias
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Romero, R.; Dey, S.K.; Fisher, S.J. Preterm Labor: One Syndrome, Many Causes. Science 2014, 345, 760–765. [Google Scholar] [CrossRef] [PubMed]
- Davis, L.; Edwards, H.; Mohay, H.; Wollin, J. The Impact of Very Premature Birth on the Psychological Health of Mothers. Early Hum. Dev. 2003, 73, 61–70. [Google Scholar] [CrossRef] [PubMed]
- Goldenberg, R.L.; Culhane, J.F.; Iams, J.D.; Romero, R. Epidemiology and Causes of Preterm Birth. Lancet 2008, 371, 75–84. [Google Scholar] [CrossRef] [PubMed]
- Jena, B.H.; Biks, G.A.; Gete, Y.K.; Gelaye, K.A. Incidence of Preterm Premature Rupture of Membranes and Its Association with Inter-Pregnancy Interval: A Prospective Cohort Study. Sci. Rep. 2022, 12, 5714. [Google Scholar] [CrossRef]
- Bonuccelli, G.A.; Negrini, R.; da Silva Ferreira, R.D. Premature Birth in Women with Endometriosis: A Systematic Review and Meta-Analysis. Reprod. Sci. 2022, 29, 250–259. [Google Scholar] [CrossRef]
- Noor, S.; Nazar, A.F.; Bashir, R.; Sultana, R. Prevalance of PPROM and Its Outcome. J. Ayub Med. Coll. Abbottabad JAMC 2007, 19, 14–17. [Google Scholar]
- Goldenberg, R.L.; Rouse, D.J. Prevention of Premature Birth. N. Engl. J. Med. 1998, 339, 313–320. [Google Scholar] [CrossRef]
- WHO. Preterm Birth. Available online: https://www.who.int/news-room/fact-sheets/detail/preterm-birth (accessed on 11 January 2023).
- CDC. Preterm Birth|Maternal and Infant Health|Reproductive Health. Available online: https://www.cdc.gov/reproductivehealth/maternalinfanthealth/pretermbirth.htm (accessed on 11 January 2023).
- Stewart, A.; Graham, E. Preterm Birth: An Overview of Risk Factors and Obstetrical Management. Dev. Disabil. Res. Rev. 2010, 16, 285–288. [Google Scholar] [CrossRef]
- Agrawal, V.; Hirsch, E. Intrauterine Infection and Preterm Labor. Semin. Fetal Neonatal Med. 2012, 17, 12–19. [Google Scholar] [CrossRef]
- Green, E.S.; Arck, P.C. Pathogenesis of Preterm Birth: Bidirectional Inflammation in Mother and Fetus. Semin. Immunopathol. 2020, 42, 413–429. [Google Scholar] [CrossRef]
- Ye, R.D.; Sun, L. Emerging Functions of Serum Amyloid A in Inflammation. J. Leukoc. Biol. 2015, 98, 923–929. [Google Scholar] [CrossRef] [PubMed]
- Malle, E.; Steinmetz, A.; Raynes, J.G. Serum Amyloid A (SAA): An Acute Phase Protein and Apolipoprotein. Atherosclerosis 1993, 102, 131–146. [Google Scholar] [CrossRef] [PubMed]
- Urieli-Shoval, S.; Linke, R.P.; Matzner, Y. Expression and Function of Serum Amyloid A, a Major Acute-Phase Protein, in Normal and Disease States. Curr. Opin. Hematol. 2000, 7, 64–69. [Google Scholar] [CrossRef] [PubMed]
- Chen, L.; Deng, H.; Cui, H.; Fang, J.; Zuo, Z.; Deng, J.; Li, Y.; Wang, X.; Zhao, L. Inflammatory Responses and Inflammation-Associated Diseases in Organs. Oncotarget 2018, 9, 7204–7218. [Google Scholar] [CrossRef] [PubMed]
- Çetinkaya, M.; Özkan, H.; Köksal, N.; Akacı, O.; Özgür, T. Comparison of the Efficacy of Serum Amyloid A, C-Reactive Protein, and Procalcitonin in the Diagnosis and Follow-up of Necrotizing Enterocolitis in Premature Infants. J. Pediatr. Surg. 2011, 46, 1482–1489. [Google Scholar] [CrossRef] [PubMed]
- Sandri, S.; Urban Borbely, A.; Fernandes, I.; Mendes de Oliveira, E.; Knebel, F.H.; Ruano, R.; Zugaib, M.; Filippin-Monteiro, F.; Bevilacqua, E.; Campa, A. Serum Amyloid A in the Placenta and Its Role in Trophoblast Invasion. PLoS ONE 2014, 9, e90881. [Google Scholar] [CrossRef]
- Pepys, M.B.; Hirschfield, G.M. C-Reactive Protein: A Critical Update. J. Clin. Investig. 2003, 111, 1805–1812. [Google Scholar] [CrossRef]
- Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews. BMJ 2021, 372, n71. [Google Scholar] [CrossRef]
- Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses. Available online: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed on 11 January 2023).
- Kayabas, H.; Bildircin, F.; Avci, B.; Karli, P.; Ozdemir, A.; Alper, T. Serum Amyloid-a May Be an Early Marker in Diagnosis of Preterm Premature Rupture of Membrane and Chorioamnionitis. Ann. Med. Res. 2019, 26, 2802. [Google Scholar] [CrossRef]
- Ibrahim, M.I.; Ellaithy, M.I.; Hussein, A.M.; Nematallah, M.M.; Allam, H.A.; Abdelhamid, A.S.; Harara, R.M.; Riad, A.A.; Rafaat, T.A. Measurement of Maternal Serum Amyloid A as a Novel Marker of Preterm Birth. J. Matern. Fetal Neonatal Med. 2021, 34, 2467–2472. [Google Scholar] [CrossRef]
- Çekmez, Y.; Çekmez, F.; Özkaya, E.; Pirgon, Ö.; Yılmaz, Z.; Yılmaz, E.A.; Korkmaz, V.; Süer, N.; Küçüközkan, T. Proadrenomedullin and Serum Amyloid A as a Predictor of Subclinical Chorioamnionitis in Preterm Premature Rupture of Membranes. J. Interferon Cytokine Res. 2013, 33, 694–699. [Google Scholar] [CrossRef]
- Köseoğlu, S.; Guzel, A.; Deveer, R.; Tokmak, A.; Engin-Ustun, Y.; Özdas, S.; Danışman, N. Maternal Serum Amyloid A Levels in Pregnancies Complicated with Preterm Prelabour Rupture of Membranes. Pol. Gynaecol. 2014, 85, 516–520. [Google Scholar] [CrossRef] [PubMed]
- ElShourbagy, M.A.A.; Hemeda, H.M.M.; Islam, B.A. Maternal Serum Amyloid A Level in Pregnancies Complicated with Preterm Premature Rupture of Membranes. Egypt. J. Hosp. Med. 2017, 68, 904–909. [Google Scholar] [CrossRef]
- Lawn, J.E.; Gravett, M.G.; Nunes, T.M.; Rubens, C.E.; Stanton, C.; the GAPPS Review Group. Global Report on Preterm Birth and Stillbirth (1 of 7): Definitions, Description of the Burden and Opportunities to Improve Data. BMC Pregnancy Childbirth 2010, 10, S1. [Google Scholar] [CrossRef]
- Lin, Y.; Zhu, P.; Wang, W.; Sun, K. Serum Amyloid A, a Host-Derived DAMP in Pregnancy? Front. Immunol. 2022, 13, 978929. [Google Scholar] [CrossRef]
- Ebert, R.; Benisch, P.; Krug, M.; Zeck, S.; Meißner-Weigl, J.; Steinert, A.; Rauner, M.; Hofbauer, L.; Jakob, F. Acute Phase Serum Amyloid A Induces Proinflammatory Cytokines and Mineralization via Toll-like Receptor 4 in Mesenchymal Stem Cells. Stem Cell Res. 2015, 15, 231–239. [Google Scholar] [CrossRef]
- Puro, N.; Kelly, R.J.; Bodas, M.; Feyereisen, S. Estimating the Differences in Caesarean Section (C-Section) Rates between Public and Privately Insured Mothers in Florida: A Decomposition Approach. PLoS ONE 2022, 17, e0266666. [Google Scholar] [CrossRef]
- Qin, B.; Ma, N.; Tang, Q.; Wei, T.; Yang, M.; Fu, H.; Hu, Z.; Liang, Y.; Yang, Z.; Zhong, R. Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) Were Useful Markers in Assessment of Inflammatory Response and Disease Activity in SLE Patients. Mod. Rheumatol. 2016, 26, 372–376. [Google Scholar] [CrossRef]
- Xiong, S.; Dong, L.; Cheng, L. Neutrophils in Cancer Carcinogenesis and Metastasis. J. Hematol. Oncol. 2021, 14, 173. [Google Scholar] [CrossRef]
- Jain, S.; Gautam, V.; Naseem, S. Acute-Phase Proteins: As Diagnostic Tool. J. Pharm. Bioallied Sci. 2011, 3, 118–127. [Google Scholar] [CrossRef]
- Arnon, S.; Litmanovitz, I.; Regev, R.H.; Bauer, S.; Shainkin-Kestenbaum, R.; Dolfin, T. Serum Amyloid A: An Early and Accurate Marker of Neonatal Early-Onset Sepsis. J. Perinatol. 2007, 27, 297–302. [Google Scholar] [CrossRef] [PubMed]
- Bengnér, J.; Quttineh, M.; Gäddlin, P.-O.; Salomonsson, K.; Faresjö, M. Serum Amyloid A—A Prime Candidate for Identification of Neonatal Sepsis. Clin. Immunol. 2021, 229, 108787. [Google Scholar] [CrossRef] [PubMed]
- Dorum, B.A.; Özkan, H.; Çakir, S.Ç.; Köksal, N.; Gözal, Z.; Çelebi, S.; Hacimustafoğlu, M. The Diagnostic Value of Serum Amyloid A in Early-Onset Neonatal Sepsis in Premature Infants. HK J. Paediatr. 2021, 26, 8–13. [Google Scholar]
- Yuan, H.; Huang, J.; Lv, B.; Yan, W.; Hu, G.; Wang, J.; Shen, B. Diagnosis Value of the Serum Amyloid A Test in Neonatal Sepsis: A Meta-Analysis. BioMed Res. Int. 2013, 2013, 520294. [Google Scholar] [CrossRef]
Authors | Year | Type of Study | No. Participants (Preterm/Control) | Primary Outcome | Mean SAA PTB | Mean SAA Control | p-Value |
---|---|---|---|---|---|---|---|
Ibrahim et al. [23] | 2019 | Case control | 58 (29/29) | PTB | 6.24 + 2.69 mg/l | 1.21 + 0.69 mg/l | <0.001 |
Cekmez et al. [24] | 2013 | Case control | 63 (43/20) | PROM | 69 + 9 mg/mL | 8.2 + 4.52 mg/mL | <0.05 |
Kayabas et al. [22] | 2019 | Cohort study | 40 (20/20) | PROM | 80 + 44 μg/ml | 10 + 7.2 μg/ml | <0.05 |
Köseoğlu et al. [25] | 2014 | Case control | 88 (44/44) | PROM | 905.16 ± 2652.79 ng/mL | 72.71 ± 100.09 ng/ml | 0.041 |
ElShourbagy et al. [26] | 2017 | Cross sectional study | 58 (29/29) | PROM | 2.50 + 1.42 | 1.05 + 1.34 | 0.002 |
Authors | Selection | Comparability | Exposure | Total | |||||
---|---|---|---|---|---|---|---|---|---|
Item 1 | Item 2 | Item 3 | Item 4 | Item 5 | Item 6 | Item 7 | Item 8 | ||
Ibrahim et al. [23] | ⋆ | ⋆ | ⋆ | ⋆ | ⋆⋆ | ⋆ | ⋆ | ⋆ | 9 |
Cekmez et al. [24] | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 6 | ||
Kayabas et al. [22] | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | ⋆ | 8 |
Köseoğlu et al. [25] | ⋆ | ⋆ | ⋆ | ⋆⋆ | ⋆ | ⋆ | ⋆ | 7 | |
ElShourbagy et al. [26] | ⋆ | ⋆ | ⋆ | ⋆ | ⋆⋆ | ⋆ | ⋆ | ⋆ | 9 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chiriac, I.-E.; Vilceanu, N.; Maghiar, A.; Andrei, C.; Hanganu, B.; Daina, L.G.; Dunarintu, S.; Buhas, L.-C. Maternal Serum Amyloid A as a Marker of Preterm Birth/PROM: A Systematic Review and Meta-Analysis. Medicina 2023, 59, 1025. https://doi.org/10.3390/medicina59061025
Chiriac I-E, Vilceanu N, Maghiar A, Andrei C, Hanganu B, Daina LG, Dunarintu S, Buhas L-C. Maternal Serum Amyloid A as a Marker of Preterm Birth/PROM: A Systematic Review and Meta-Analysis. Medicina. 2023; 59(6):1025. https://doi.org/10.3390/medicina59061025
Chicago/Turabian StyleChiriac, Ioana-Evelina, Narcis Vilceanu, Adrian Maghiar, Csep Andrei, Bianca Hanganu, Lucia Georgeta Daina, Simona Dunarintu, and Liana-Camelia Buhas. 2023. "Maternal Serum Amyloid A as a Marker of Preterm Birth/PROM: A Systematic Review and Meta-Analysis" Medicina 59, no. 6: 1025. https://doi.org/10.3390/medicina59061025
APA StyleChiriac, I. -E., Vilceanu, N., Maghiar, A., Andrei, C., Hanganu, B., Daina, L. G., Dunarintu, S., & Buhas, L. -C. (2023). Maternal Serum Amyloid A as a Marker of Preterm Birth/PROM: A Systematic Review and Meta-Analysis. Medicina, 59(6), 1025. https://doi.org/10.3390/medicina59061025